Briefly, the test determines if the PTEN gene is functioning properly, as it is a tumor suppressor gene that is linked with cell regulation. If patients have a low level of the protein, studies have shown a progression of the cancer, while if the levels remain higher, the less chances of...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, tumors, Chemotherapy, markers, PTEN gene, Myriad, diagnositic tests
Wow, huge bills and she was able to borrow 45k but then at admitting time, the hospital wanted another 65k. This was at the MD Anderson Center in Texas. She states that she could pay for her chemotherapy if she washes out here entire retirement funds, tough decision and so now she keeps fighting...
Great interview from the Wall Street Journal, I guess when it comes time to go over the costs a patient gets to select to either find a method of payment if they can, or the other choice (no treatment) and we all know what the horrible results can be from there. The physicians are there to treat...